R. Becker

发表

Herg K+ Channel-Dependent Apoptosis and Cell Cycle Arrest in Human Glioblastoma Cells

H. Katus, Dierk Thomas, P. Schweizer, 2014, PloS one.

Regulation of two‐pore‐domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein

E. Ficker, A. Bauer, J. Gierten, 2008, British journal of pharmacology.

Carvedilol targets human K2P3.1 (TASK1) K+ leak channels

H. Katus, Ann-Kathrin Rahm, E. Ficker, 2011, British journal of pharmacology.

Prevalence, kinetic changes and possible reasons of elevated cardiac troponin T in patients with AV nodal re-entrant tachycardia

H. Katus, E. Giannitsis, D. Thomas, 2012, Acute cardiac care.

Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy

H. Katus, F. Niroomand, A. Bauer, 2003, Basic Research in Cardiology.

Biophysical properties of mutant KCNQ1 S277L channels linked to hereditary long QT syndrome with phenotypic variability.

H. Katus, Dierk Thomas, P. Schweizer, 2011, Biochimica et biophysica acta.

Inhibition of cardiac Kir2.1-2.3 channels by beta3 adrenoreceptor antagonist SR 59230A.

H. Katus, Dierk Thomas, E. Zitron, 2012, Biochemical and biophysical research communications.

In vitro modulation of HERG channels by organochlorine solvent trichlormethane as potential explanation for proarrhythmic effects of chloroform.

H. Katus, J. Greten, Dierk Thomas, 2006, Toxicology letters.

[Molecular basis of primary electrical heart diseases].

E. Zitron, C. Kiesecker, E. Scholz, 2005, Herzschrittmachertherapie & Elektrophysiologie.

Alternative splicing determines mRNA translation initiation and function of human K2P10.1 K+ channels

H. Katus, Dierk Thomas, Ann-Kathrin Rahm, 2011, The Journal of physiology.

Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death.

H. Goldschmidt, H. Katus, U. Hegenbart, 2008, Heart rhythm.

Modulation of K2P2.1 and K2P10.1 K+ channel sensitivity to carvedilol by alternative mRNA translation initiation

H. Katus, P. Schweizer, D. Thomas, 2014, British journal of pharmacology.

Enhancement of K2P2.1 (TREK1) background currents expressed in Xenopus oocytes by voltage-gated K+ channel β subunits.

H. Katus, Dierk Thomas, P. Schweizer, 2012, Life sciences.

Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels

H. Katus, Dierk Thomas, C. Schmidt, 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

Regulation of apoptosis in HL‐1 cardiomyocytes by phosphorylation of the receptor tyrosine kinase EphA2 and protection by lithocholic acid

H. Katus, P. Schweizer, I. Staudacher, 2012, British Journal of Pharmacology.

Implantable Defibrillators With Enhanced Detection Algorithms: Detection Performance and Safety Results from the PainFree SST Study

C. Garutti, H. Mayr, T. Lawo, 2014, Pacing and clinical electrophysiology : PACE.

Biological Heart Rate Reduction Through Genetic Suppression of Gαs Protein in the Sinoatrial Node

H. Katus, Dierk Thomas, P. Lugenbiel, 2012, Journal of the American Heart Association.

Identification and functional characterization of zebrafish K(2P)10.1 (TREK2) two-pore-domain K(+) channels.

H. Katus, Dierk Thomas, J. Gierten, 2012, Biochimica et biophysica acta.

Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K(+) (K2 ₂p) channels.

H. Katus, Dierk Thomas, C. Schmidt, 2013, European journal of pharmacology.

Functional characterization of zebrafish K2P18.1 (TRESK) two-pore-domain K+ channels

H. Katus, Dierk Thomas, C. Schmidt, 2013, Naunyn-Schmiedeberg's Archives of Pharmacology.

PKC‐dependent activation of human K2P18.1 K+ channels

H. Katus, Dierk Thomas, Ann-Kathrin Rahm, 2012, British journal of pharmacology.

Cesium chloride induced ventricular arrhythmias in dogs: three-dimensional activation patterns and their relation to the cesium dose applied

W. Kübler, A. Bauer, K. Freigang, 2000, Basic Research in Cardiology.

Electrophysiological fi ndings in Fabry cardiomyopathy: mapping the maze of risk stratifi cation

A. Warth, P. Schnabel, H. Katus, 2012 .

cAMP Sensitivity of HCN Pacemaker Channels Determines Basal Heart Rate But Is Not Critical for Autonomic Rate Control

A. Draguhn, C. Bruehl, H. Katus, 2010, Circulation. Arrhythmia and electrophysiology.

Identification and functional characterization of the novel human ether-a-go-go-related gene (hERG) R744P mutant associated with hereditary long QT syndrome 2.

H. Katus, Dierk Thomas, P. Schweizer, 2012, Biochemical and biophysical research communications.

Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of action

H. Katus, E. Zitron, E. Scholz, 2013, Naunyn-Schmiedeberg's Archives of Pharmacology.

Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation.

A. Draguhn, C. Bruehl, I. Schlichting, 2013, European heart journal.

EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy.

J. Daubert, F. Cosío, P. Kirchhof, 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Study Design of the Man and Machine Trial: A Prospective International Controlled Noninferiority Trial Comparing Manual with Robotic Catheter Ablation for Treatment of Atrial Fibrillation

K. Kuck, A. Natale, L. Di Biase, 2013, Journal of cardiovascular electrophysiology.

Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation

H. Katus, Dierk Thomas, P. Schweizer, 2011, Drug design, development and therapy.

Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study.

H. Katus, Dierk Thomas, P. Lugenbiel, 2013, European heart journal.

Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model.

M. Koch, H. Katus, Dierk Thomas, 2011, Cardiovascular research.

Impact of Structural Heart Disease on the Acute Complication Rate in Atrial Fibrillation Ablation: Results from the German Ablation Registry

J. Brachmann, L. Eckardt, K. Kuck, 2014, Journal of cardiovascular electrophysiology.

Anti-KCNQ1 K⁺ channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathy.

H. Katus, Dierk Thomas, C. Schmidt, 2013, Cardiovascular research.

Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels

H. Katus, Dierk Thomas, C. Schmidt, 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of action

H. Katus, E. Zitron, E. Scholz, 2013, Naunyn-Schmiedeberg's Archives of Pharmacology.

Effects of β-blocker therapy on electrocardiographic and echocardiographic characteristics of left ventricular noncompaction

H. Katus, B. Meder, D. Mereles, 2015, Clinical Research in Cardiology.

Genetic suppression of Gαs protein provides rate control in atrial fibrillation

H. Katus, Dierk Thomas, P. Lugenbiel, 2012, Basic Research in Cardiology.

Mechanisms of zolpidem‐induced long QT syndrome: acute inhibition of recombinant hERG K+ channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells

H. Katus, C. Schmidt, I. Deschênes, 2013, British journal of pharmacology.

Impaired ion channel function related to a common KCNQ1 mutation - implications for risk stratification in long QT syndrome 1.

H. Katus, Dierk Thomas, P. Schweizer, 2012, Gene.

TASK1 (K2P3.1) K+ channel inhibition by endothelin‐1 is mediated through Rho kinase‐dependent phosphorylation

J. Gierten, E. Zitron, H. Katus, 2012, British journal of pharmacology.

Effects of propafenone on anisotropic conduction properties within the three-dimensional structure of the canine ventricular wall

W. Kübler, A. Bauer, J. Senges, 2001, Basic Research in Cardiology.

Cardioverter defibrillator therapy in the primary and secondary prevention of sudden cardiac death

H. Katus, Dierk Thomas, R. Becker, 2012 .

Paroxysmal Atrial Fibrillation Is More Prevalent than Persistent Atrial Fibrillation in Acute Stroke and Transient Ischemic Attack Patients

W. Hacke, P. Ringleb, E. Jenetzky, 2011, Cerebrovascular Diseases.

Continuous Stroke Unit Electrocardiographic Monitoring Versus 24-Hour Holter Electrocardiography for Detection of Paroxysmal Atrial Fibrillation After Stroke

P. Kirchhof, W. Hacke, P. Ringleb, 2012, Stroke.

Electrocardiography for Detection of Paroxysmal Atrial Fibrillation After Stroke Continuous Stroke Unit Electrocardiographic Monitoring Versus 24-Hour Holter

P. Kirchhof, W. Hacke, P. Ringleb, 2012 .

Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/quinidine

H. Katus, Dierk Thomas, P. Schweizer, 2010, Clinical Research in Cardiology.

Efficacy, High Procedural Safety And Rapid Optimization Of Cryoballoon Atrial Fibrillation Ablation In The Hands Of A New Operator.

H. Katus, Dierk Thomas, P. Lugenbiel, 2016, Journal of atrial fibrillation.

Radiation therapy-induced electrical reset of an implantable cardioverter defibrillator device located outside the irradiation field.

Hugo A Katus, H. Katus, Dierk Thomas, 2004, Journal of electrocardiology.

Anxiety Disorders in Patients with Implantable Cardioverter Defibrillators: Frequency, Course, Predictors, and Patients’ Requests for Treatment

B. Löwe, M. Hartmann, W. Herzog, 2014, Pacing and clinical electrophysiology : PACE.

Genetic suppression of atrial fibrillation using a dominant-negative ether-a-go-go-related gene mutant.

H. Katus, Dierk Thomas, A. Bauer, 2012, Heart rhythm.